Abstract
Squamous cell carcinoma of the penis is rare in daily practice. Epidermal growth factor receptor is widely overexpressed in this type of cancer. In a metastatic situation, chemotherapy has modest efficacy. Agents targeting this receptor, including Cetuximab, are effective as monotherapy or in combination with chemotherapy. The finding was fortuitous in the anatomopathological analysis of a resection specimen for phimosis. It progressed first to the inguinal lymph nodes 3 months after surgery and then rapidly to the lungs and liver after the first line of chemotherapy. Cetuximab monotherapy in the second line of therapy was well tolerated and showed a complete response after 6 months of treatment. This response has been maintained for 5 years of treatment. The efficacy of agents targeting the Epidermal Growth Factor Receptor in squamous cell carcinoma of the penis opens the way to therapeutic optimization.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
